| Field | Specification |
|---|---|
| Mfr No | |
| Assay Type | |
| Detection Method | |
| Product Type | |
| Sample Type(s) | Serum, Plasma and Cell culture supernatant. |
| Shipping | |
| Species | |
| Storage | |
| Target |
Overview
SARS-CoV-2 RBD (BA.4/5) ELISA Kit is an ELISA-based immunoassay designed for quantitative measurement of RBD (SARS-CoV-2) in research samples. It is commonly used to generate traceable concentration data for biomarker discovery, pathway studies, and comparative analyses across experimental conditions.
Key elements and design rationale
- Assay format: Quantitative Colorimetric ELISA. The format defines how signal scales with analyte abundance and how results are interpreted across a standard curve.
- Sample compatibility: Intended for Serum, Plasma and Cell culture supernatant. matrices. As with most immunoassays, matrix composition can influence apparent signal and should be evaluated with dilution linearity and spike-recovery concepts.
- Recovery reference: Typical recovery is reported as 80-120%. Recovery helps assess whether the sample matrix interferes with detection of spiked analyte.
This kit is supplied for research use in laboratory settings where defined, quantitative readouts are needed for experimental interpretation.
Biological background
RBD is a commonly studied research analyte. Its biological roles and regulation can be context-dependent (cell type, tissue state, and experimental perturbation). For authoritative gene/protein function summaries and nomenclature, researchers typically consult curated databases.
Research relevance and current trends
- Biomarker translation in RUO settings: Increasing use of quantitative immunoassays to stratify experimental cohorts, track longitudinal changes, and benchmark model systems.
- Matrix-aware assay design: Greater emphasis on dilution linearity, spike-recovery, and control concepts to reduce matrix-driven artifacts in serum/plasma and complex lysates.
- Integration with multi-omics: ELISA measurements are often used alongside transcriptomics and proteomics to connect abundance changes with pathway activity and phenotype.
Common research applications
- Comparative quantification: Measure relative changes in analyte levels across treatments, time points, or genotypes to support mechanistic hypotheses.
- Assay development and standardization: Generate reproducible concentration inputs for method qualification, inter-operator comparisons, or bridging studies across platforms.
- Model and sample characterization: Profile baseline and stimulated levels to help interpret immune, endocrine, neurodegenerative, or metabolic phenotypes (as relevant to the target).
Interpretation typically focuses on direction and magnitude of change in the context of controls and sample handling metadata, rather than single-point absolute values.
Notes for experimental interpretation
- Matrix effects: Hemolysis, lipemia, and high protein content can alter background and apparent concentration. Consider consistent collection/processing and evaluate dilution behavior.
- Isoforms and modified forms: Some targets exist as isoforms, fragments, or post-translationally modified species. Ensure the measured form aligns with the biological question and the kit’s intended analyte definition.
- Control concepts: Use negative/blank controls, replicate wells, and—when feasible—orthogonal confirmation (e.g., WB or MS) to strengthen conclusions.
What does this ELISA kit measure?
This sandwich ELISA kit is designed to quantitatively measure RBD in biological samples. It uses a validated antibody pair with high specificity for the target antigen, making it suitable for research in Molecular & Cellular Biology applications.
What sample types are compatible with this kit?
This kit has been validated for use with Serum and Plasma and Cell culture supernatant.. Samples should be diluted as recommended in the protocol to fall within the standard curve range. Cross-reactivity with other matrices has not been systematically evaluated and should be tested by the user.
How should I prepare my samples before running the assay?
Samples should be collected, processed, and stored according to established best practices for the matrix type. Avoid repeated freeze-thaw cycles. Centrifuge samples containing particulates at 2,000?3,000 ? g for 10 minutes. Dilute samples in the provided assay diluent and run in duplicate. Refer to the kit insert for recommended dilution factors.
Can this kit be used for clinical diagnostic purposes?
No. This kit is intended for research use only (RUO) and is not approved or validated for clinical diagnosis, patient management, or therapeutic monitoring. Results obtained with this kit should not be used to make clinical decisions.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
